IP Library Granted Patent US 8,098,473
Granted Patent B2
US 8,098,473 · App. 12/986,974 · Granted Jan 17, 2012

Component module for a reduced pressure treatment system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,098,473
App. No.
12/986,974
Granted
Jan 17, 2012
Kind
B2
Abstract

A reduced pressure treatment system includes a control unit having a control system and a reduced pressure source. The reduced pressure treatment system further includes a manifold unit in fluid communication with the reduced pressure source and a component module to augment treatment. The component module is configured to communicate with the control system of the control unit, and the component module includes a first mounting region configured to be coupled to a complimentary mounting region of the control unit. The component module further includes a second mounting region identical to the complimentary mounting region of the control unit to allow a second component module to be coupled to the first component module.

Claims (34)

1. A reduced pressure treatment system for treating a tissue site of a patient, the system comprising:

a control unit having a control system and a reduced pressure source;

a manifold unit in fluid communication with the reduced pressure source;

a component module to augment treatment and configured to communicate with the control system of the control unit, the component module having a first mounting region configured to be coupled to a complimentary mounting region of the control unit, the component module having a second mounting region identical to the complimentary mounting region of the control unit to allow a second component module to be coupled to the first component module.

2. The reduced pressure treatment system of claim 1 , wherein the first mounting region further comprises:

a rim; and

a recessed end surface.

3. The reduced pressure treatment system of claim 2 , wherein the first mounting region further comprises:

a mounting assembly having a latch.

4. The reduced pressure treatment system of claim 1 , wherein the complimentary mounting region of the control unit further comprises:

a shoulder; and

an extension surface.

5. The reduced pressure treatment system of claim 1 , wherein:

the first mounting region further comprises a rim, a recessed end surface, and a latch;

the complimentary mounting region of the control unit further comprises a shoulder and an extension surface; and

the recessed end surface is configured to receive the extension surface, and the latch is configured to fasten to the extension surface to secure the component module to the control unit.

6. The reduced pressure treatment system of claim 5 , wherein the extension surface includes a ridge and the latch includes a fastener bar that overlaps the ridge to secure the component module to the control unit.

7. The reduced pressure treatment system of claim 1 , wherein the component module and the control system communicate using a controller area network (CAN) protocol.

8. The reduced pressure treatment system of claim 1 , wherein the control system further comprises a treatment controller and a communication controller.

9. A reduced pressure treatment system for treating a tissue site of a patient, the system comprising:

a control unit having a control system and a reduced pressure source;

a manifold unit in fluid communication with the reduced pressure source;

a plurality of component modules to augment treatment, each of the plurality of component modules configured to communicate with the control system, at least one of the plurality of components modules configured to be coupled to both the control unit and another of the plurality of component modules.

10. The reduced pressure treatment system of claim 9 , wherein the plurality of component modules and the control system communicate using a controller area network (CAN) protocol.

11. The reduced pressure treatment system of claim 9 , wherein the component module is a wound camera.

12. The reduced pressure treatment system of claim 9 , wherein the component module is a cyclic skin stretcher.

13. The reduced pressure treatment system of claim 9 , wherein the component module is a capacitive volume and wound contour mapping module.

14. The reduced pressure treatment system of claim 9 , wherein the component module is a wound bed pH monitor.

15. The reduced pressure treatment system of claim 9 , wherein the component module is a wound climate control module.

16. The reduced pressure treatment system of claim 9 , wherein the component module is a wound moisture and temperature monitor.

17. The reduced pressure treatment system of claim 9 , wherein the component module is an electrical stimulation module.

18. The reduced pressure treatment system of claim 9 , wherein the component module is an ultraviolet therapy module.

19. The reduced pressure treatment system of claim 9 , wherein the component module is a wound healing marker measurement module.

20. The reduced pressure treatment system of claim 9 , wherein the control system further comprises a treatment controller and a communication controller.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2014
From: LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK; BEARD, MARK STEPHEN JAMES; TOUT, AIDAN MARCUS
To: KCI LICENSING, INC.
Reel/Frame 034455/0104 →